Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Intangibles (2018 - 2025)

Collegium Pharmaceutical has reported Intangibles over the past 6 years, most recently at $669.5 million for Q4 2025.

  • Quarterly results put Intangibles at $669.5 million for Q4 2025, down 24.89% from a year ago — trailing twelve months through Dec 2025 was $669.5 million (down 24.89% YoY), and the annual figure for FY2025 was $669.5 million, down 24.89%.
  • Intangibles for Q4 2025 was $669.5 million at Collegium Pharmaceutical, down from $725.0 million in the prior quarter.
  • Over the last five years, Intangibles for COLL hit a ceiling of $956.2 million in Q3 2022 and a floor of $268.7 million in Q4 2021.
  • Median Intangibles over the past 5 years was $669.5 million (2025), compared with a mean of $651.9 million.
  • Biggest five-year swings in Intangibles: tumbled 62.92% in 2024 and later surged 121.3% in 2025.
  • Collegium Pharmaceutical's Intangibles stood at $268.7 million in 2021, then soared by 111.17% to $567.5 million in 2022, then decreased by 25.69% to $421.7 million in 2023, then soared by 111.38% to $891.4 million in 2024, then decreased by 24.89% to $669.5 million in 2025.
  • The last three reported values for Intangibles were $669.5 million (Q4 2025), $725.0 million (Q3 2025), and $780.5 million (Q2 2025) per Business Quant data.